These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28098570)

  • 41. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.
    Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H
    Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
    Gao HF; Li AN; Yang JJ; Chen ZH; Xie Z; Zhang XC; Su J; Lou NN; Yan HH; Han JF; Wu YL
    Clin Lung Cancer; 2017 Jan; 18(1):85-91. PubMed ID: 27461774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm.
    Go H; Kim DW; Kim D; Keam B; Kim TM; Lee SH; Heo DS; Bang YJ; Chung DH
    J Thorac Oncol; 2013 Nov; 8(11):1445-50. PubMed ID: 24128715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
    Yang SH; Baek HA; Lee HJ; Park HS; Jang KY; Kang MJ; Lee DG; Lee YC; Moon WS; Chung MJ
    Oncol Rep; 2010 Aug; 24(2):311-9. PubMed ID: 20596615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma.
    Lee H; Kim JM; Huang SM; Park SK; Kim DH; Kim DH; Lee CS; Suh KS; Yi ES; Kim KH
    Pathol Res Pract; 2011 Jul; 207(7):428-32. PubMed ID: 21680106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
    Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
    Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
    Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ROS1 copy number alterations are frequent in non-small cell lung cancer.
    Clavé S; Gimeno J; Muñoz-Mármol AM; Vidal J; Reguart N; Carcereny E; Pijuan L; Menéndez S; Taus Á; Mate JL; Serrano S; Albanell J; Espinet B; Arriola E; Salido M
    Oncotarget; 2016 Feb; 7(7):8019-28. PubMed ID: 26783962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.
    Park S; Choi YL; Sung CO; An J; Seo J; Ahn MJ; Ahn JS; Park K; Shin YK; Erkin OC; Song K; Kim J; Shim YM; Han J
    Histol Histopathol; 2012 Feb; 27(2):197-207. PubMed ID: 22207554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
    Awad MM; Oxnard GR; Jackman DM; Savukoski DO; Hall D; Shivdasani P; Heng JC; Dahlberg SE; Jänne PA; Verma S; Christensen J; Hammerman PS; Sholl LM
    J Clin Oncol; 2016 Mar; 34(7):721-30. PubMed ID: 26729443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.
    Ikeda S; Okamoto T; Okano S; Umemoto Y; Tagawa T; Morodomi Y; Kohno M; Shimamatsu S; Kitahara H; Suzuki Y; Fujishita T; Maehara Y
    J Thorac Oncol; 2016 Jan; 11(1):62-71. PubMed ID: 26762740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different biomarkers in non-small cell lung cancer in blood vessel invasion.
    Zhang C; Liu Y; Guo S; Zhang J
    Cell Biochem Biophys; 2014 Nov; 70(2):777-84. PubMed ID: 24801771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung adenocarcinoma.
    Koga K; Hamasaki M; Kato F; Aoki M; Hayashi H; Iwasaki A; Kataoka H; Nabeshima K
    Lung Cancer; 2013 Dec; 82(3):413-9. PubMed ID: 24094902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
    Tsao MS; Yang Y; Marcus A; Liu N; Mou L
    Hum Pathol; 2001 Jan; 32(1):57-65. PubMed ID: 11172296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.
    Tsakonas G; Botling J; Micke P; Rivard C; LaFleur L; Mattsson J; Boyle T; Hirsch FR; Ekman S
    Lung Cancer; 2019 Jul; 133():69-74. PubMed ID: 31200831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
    Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
    Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.